Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Precipio, Inc. Director's Dealing 2014

May 23, 2014

34807_dirs_2014-05-23_2cfb98f2-4dac-40bf-9a71-aa33dd763170.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TRANSGENOMIC INC (TBIO)
CIK: 0001043961
Period of Report: 2014-05-22

Reporting Person: Kopp LeRoy C (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-05-22 Common Stock S 413050 $3.70 Disposed 0 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 8333 Indirect

Footnotes

F1: The figure reported reflects the issuer's 1-for-12 reverse stock split effective on January 27, 2014.

F2: The filing of this report shall not be deemed an admission that Mr. Kopp is the beneficial owner of these shares for purposes of Section 16 of the Exchange Act of 1934.